SG Americas Securities
CATX icon

SG Americas Securities’s Perspective Therapeutics CATX Stock Holding History

SG Americas Securities’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
+35,745
New +$135K ﹤0.01% 3025
2025
Q4 		– Sell
-13,538
Closed -$46K – 3616
2025
Q3 		$46K Buy
+13,538
New +$49.4K ﹤0.01% 3210
2025
Q2 		– Sell
-20,789
Closed -$44K – 2997
2025
Q1 		$44K Sell
20,789
-5,299
-20% -$15.9K ﹤0.01% 3264
2024
Q4 		$83K Buy
26,088
+7,627
+41% +$62.3K ﹤0.01% 2792
2024
Q3 		$246K Buy
+18,461
New +$246K ﹤0.01% 2317

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

SG Americas Securities's CATX Position: Q2 2026 in Review

SG Americas Securities opened a new position in Perspective Therapeutics (CATX) in Q2 2026: 35,745 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #3025 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in CATX as recently as Q3 2025.

SG Americas Securities first reported a position in CATX in Q3 2024 and has held it in 5 quarters since. The position peaked at $246K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • SG Americas Securities held 35,745 shares of Perspective Therapeutics worth $122K as of Q2 2026.
  • Perspective Therapeutics was a new SG Americas Securities position in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3025 holding.
  • SG Americas Securities first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • SG Americas Securities's Perspective Therapeutics position peaked at $246K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.